- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00621374
Management of Pain in Persons With Multiple Sclerosis
January 14, 2013 updated by: Mark Jensen, University of Washington
Pilot Study of CBT and Self-hypnosis Training for Pain in Persons With Multiple Sclerosis
The purpose of this study is to see if treatments that include components of self-hypnosis training and cognitive behavioral therapy (CBT) can help decrease pain in people with MS.
Study Overview
Status
Completed
Conditions
Detailed Description
This study examined the benefits of two treatments, individually and together, for helping individuals with MS manage their pain.
We conducted a time series design in which MS subjects received all four treatment conditions in two orders (randomly assigned): (1) Control (education intervention-CONT),Self-Hypnosis Training (HYP), Cognitive Behavioral Therapy (CBT), HYP-CBT(a combination of HYP and CBT) and (2) CONT, CBT, HYP, HYP-CBT.
Subjects attended 16 60-minute treatment sessions conducted by one of the study's psychologists either at the UW,HMC or in the subject's home.
Each subject received four treatment sessions of each treatment module listed above.
Primary outcome measures were collected via the telephone and mail by research personnel blind to the treatment condition before treatment, immediately after treatment ends and one month after treatment ends.
Secondary outcome measures were collected at the same assessment points via pencil and paper interviews completed by subjects.
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98195
- University of Washington
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Chronic ongoing pain (i.e., pain at all times) with an average pain intensity of at least 4/10 on 0-10 numeric rating scale
- Pain is either worse or started since the onset of other MS symptoms.
- Pain of at least six months duration.
- Reads, speaks and understands English.
- Definitive diagnosis of multiple sclerosis (MS)
- At least 18 years of age
- Recruited from a recruitment source approved by the IRB
Exclusion Criteria:
- Severe cognitive impairment resulting in the inability to verbally comprehend, learn, and recall new auditory verbal information, as reflected by a TICS score of 20 or less.
- Currently participating in counseling and/or psychotherapy more than once a week.
- Currently taking anti-psychotic medications
- Has been hospitalized for psychiatric reasons in the past six months
- Experiencing current active suicidal ideation.
- Has received treatment or participated in a clinical trial that involved significant elements of either CBT or hypnosis within the past year.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Random Order 1
Randomization Order 1= 1)CONT, 2)CBT, 3)HYP, 4) CBT-HYP
|
There is also the possibility that the two treatments together may be even more helpful than either one alone.
Because some of the patients in this study will get both CBT and self-hypnosis, we will be able to determine if each one facilitates the efficacy of the other.
If the patients treated in this study report benefits, as we expect they will, then this will encourage us to design and complete a larger study to better understand how patients with MS would benefit from these treatments.
One treatment module is we will study is called "cognitive restructuring" or "cognitive-behavior therapy" (CBT).
In this treatment, people learn to identify negative thoughts that make them feel bad or anxious.
Such negative thoughts lead to feelings of frustration and anxiety, and can even increase the experience of pain, because they cause a person to focus more on pain.
With CBT, people learn to identify and stop these thoughts, and then replace them with more reassuring ones.
When they do this, they feel more relaxed and focus less on their pain.
As a result, they often say that they feel much better and are less aware of pain.
Self-hypnosis (HYP) is another strategy that people can learn to manage pain.
With this treatment, people learn to enter a state of focused attention, and then change how they experience pain.
Although we do not yet know how hypnosis works, research has repeatedly shown that the effects are real; when people report decreases in pain with hypnosis, scans and images of the brain's activity show decreases in the parts of the brain that process pain information.
With hypnosis, people are not just pretending to feel less pain, they actually do feel less pain.
The CONT condition for this study will include lectures that are interactive and are compelling and informative enough to be both (1) credible as an attentional control condition and (2) perceived as helpful to subjects.
The CONT condition will not, however, include instructions in making specific cognitive or behavioral changes related to pain management.
Thus, it could control for non-specific factors related to behavioral treatment, but will not impact the primary outcome measure (pain).
|
|
Experimental: Random Order 2
Randomization order 2= 1)CONT, 2)HYP, 3)CBT, 4) CBT-HYP
|
There is also the possibility that the two treatments together may be even more helpful than either one alone.
Because some of the patients in this study will get both CBT and self-hypnosis, we will be able to determine if each one facilitates the efficacy of the other.
If the patients treated in this study report benefits, as we expect they will, then this will encourage us to design and complete a larger study to better understand how patients with MS would benefit from these treatments.
One treatment module is we will study is called "cognitive restructuring" or "cognitive-behavior therapy" (CBT).
In this treatment, people learn to identify negative thoughts that make them feel bad or anxious.
Such negative thoughts lead to feelings of frustration and anxiety, and can even increase the experience of pain, because they cause a person to focus more on pain.
With CBT, people learn to identify and stop these thoughts, and then replace them with more reassuring ones.
When they do this, they feel more relaxed and focus less on their pain.
As a result, they often say that they feel much better and are less aware of pain.
Self-hypnosis (HYP) is another strategy that people can learn to manage pain.
With this treatment, people learn to enter a state of focused attention, and then change how they experience pain.
Although we do not yet know how hypnosis works, research has repeatedly shown that the effects are real; when people report decreases in pain with hypnosis, scans and images of the brain's activity show decreases in the parts of the brain that process pain information.
With hypnosis, people are not just pretending to feel less pain, they actually do feel less pain.
The CONT condition for this study will include lectures that are interactive and are compelling and informative enough to be both (1) credible as an attentional control condition and (2) perceived as helpful to subjects.
The CONT condition will not, however, include instructions in making specific cognitive or behavioral changes related to pain management.
Thus, it could control for non-specific factors related to behavioral treatment, but will not impact the primary outcome measure (pain).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
A composite of average daily pain intensity measured using a 0-10 NRS via four phone interviews performed on different days by research staff.
Time Frame: Before treatment, after each treatment module, and 1-month after the final treatment module.
|
Before treatment, after each treatment module, and 1-month after the final treatment module.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Sleep quality- Medical Outcomes Sleep Study Measure (Hays et al., 2005)
Time Frame: before treatment, after each treatment module, one month after 4th treatment modules
|
before treatment, after each treatment module, one month after 4th treatment modules
|
|
Depression- (CMDI; Nyenhuis et al., 1998)
Time Frame: before treatment, after each treatment module, one month after 4th treatment modules
|
before treatment, after each treatment module, one month after 4th treatment modules
|
|
Catastrophizing cognitions- (PCS; Sullivan et al. 1995)
Time Frame: before treatment, after each treatment module, one month after 4th treatment modules
|
before treatment, after each treatment module, one month after 4th treatment modules
|
|
Adaptive cognitions (CPAQ; McCracken et al., 2004)
Time Frame: before treatment, after each treatment module, one month after 4th treatment modules
|
before treatment, after each treatment module, one month after 4th treatment modules
|
|
Distinguishing neuropathic vs. non-neuropathic pain (S-LANSS; Bennett et al., 2005)
Time Frame: before treatment, after each treatment module, one month after 4th treatment modules
|
before treatment, after each treatment module, one month after 4th treatment modules
|
|
Pain Interference-(Brief Pain Inventory, Cleeland et al., 1994)
Time Frame: before treatment, after each treatment module, one month after 4th treatment modules
|
before treatment, after each treatment module, one month after 4th treatment modules
|
|
Impact of Fatigue (FIS; Fisk et al. 1993)
Time Frame: before treatment, after each treatment module, one month after 4th treatment modules
|
before treatment, after each treatment module, one month after 4th treatment modules
|
|
Fatigue Severity (FSS; Krupp et al., 1989)
Time Frame: before treatment, after each treatment module, one month after 4th treatment modules
|
before treatment, after each treatment module, one month after 4th treatment modules
|
|
Health Status (SF-36; Ware et al., 1992)
Time Frame: before treatment, after each treatment module, one month after 4th treatment modules
|
before treatment, after each treatment module, one month after 4th treatment modules
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Mark P Jensen, Ph.D., University of Washington
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2008
Primary Completion (Actual)
June 1, 2009
Study Completion (Actual)
June 1, 2009
Study Registration Dates
First Submitted
February 12, 2008
First Submitted That Met QC Criteria
February 21, 2008
First Posted (Estimate)
February 22, 2008
Study Record Updates
Last Update Posted (Estimate)
January 16, 2013
Last Update Submitted That Met QC Criteria
January 14, 2013
Last Verified
January 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 32022-A
- NMSS Award# PP1465
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.